OrthoPediatrics Corp. cash flow to debt ratio of -4.85% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

OrthoPediatrics Corp.'s free cash flow has increased -61.36% from $-41.31M last year to $-15.96M, signaling increasing performance

OrthoPediatrics Corp.'s debt to equity ratio is 0.31, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

OrthoPediatrics Corp.'s debt has increased relative to shareholder equity from 0.23 last year to 0.31 today, signaling weakened financials

OrthoPediatrics Corp. has negative EBITDA, making leverage ratio unreliable

OrthoPediatrics Corp.'s interest coverage ratio is -4.21, which means that the company struggles to meet interest obligations, signaling financial risk.

OrthoPediatrics Corp.'s profit margin has increased (-11.73%) in the last year from -18.47% to -16.31%, signaling increasing performance

OrthoPediatrics Corp.'s short-term assets of $256.42M exceed its short-term liabilities of $46.20M

OrthoPediatrics Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

OrthoPediatrics Corp.'s return on equity of -11.42%, is lower than 15.00%, indicating bad performance

OrthoPediatrics Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

OrthoPediatrics Corp. had positive net income in only 1.00 out of 5 years, indicating unstable earnings

OrthoPediatrics Corp. has negative free cash flow, indicating the company is burning cash rather than generating it

OrthoPediatrics Corp. has negative free cash flow, indicating cash burn

OrthoPediatrics Corp.'s yearly earnings has decreased 4.83% since last year from $-37.82M to $-39.65M, signaling decreasing performance

OrthoPediatrics Corp.'s yearly revenue has increased 15.45% since last year from $204.73M to $236.35M, signaling increasing performance

ROIC -6.41% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

OrthoPediatrics Corp.'s 3-year revenue CAGR of 24.56% is positive, indicating growing revenue over the past 3 years

OrthoPediatrics Corp. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

OrthoPediatrics Corp. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity

OrthoPediatrics Corp. has insufficient data to evaluate this check.

OrthoPediatrics Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

OrthoPediatrics Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

OrthoPediatrics Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

OrthoPediatrics Corp. is overvalued relative to its fair value price of -35.07 based on Earnings Fair Value model

OrthoPediatrics Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

OrthoPediatrics Corp. has a price-to-book ratio of 1.35x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

OrthoPediatrics Corp. has a price-to-sales ratio of 1.87x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue